These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11535313)

  • 21. A 2 amino acid shift in position leads to a substantial difference in the pattern of processing of 2 HIV-1 epitopes.
    Culshaw A; Dong T; Rowland-Jones SL
    J Acquir Immune Defic Syndr; 2012 Apr; 59(4):335-9. PubMed ID: 22217677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Codon optimization of the tat antigen of human immunodeficiency virus type 1 generates strong immune responses in mice following genetic immunization.
    Ramakrishna L; Anand KK; Mohankumar KM; Ranga U
    J Virol; 2004 Sep; 78(17):9174-89. PubMed ID: 15308713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defined flanking spacers and enhanced proteolysis is essential for eradication of established tumors by an epitope string DNA vaccine.
    Velders MP; Weijzen S; Eiben GL; Elmishad AG; Kloetzel PM; Higgins T; Ciccarelli RB; Evans M; Man S; Smith L; Kast WM
    J Immunol; 2001 May; 166(9):5366-73. PubMed ID: 11313372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant adenylate cyclase toxin of Bordetella pertussis induces cytotoxic T lymphocyte responses against HLA*0201-restricted melanoma epitopes.
    Dadaglio G; Morel S; Bauche C; Moukrim Z; Lemonnier FA; Van Den Eynde BJ; Ladant D; Leclerc C
    Int Immunol; 2003 Dec; 15(12):1423-30. PubMed ID: 14645151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Critical components of a DNA fusion vaccine able to induce protective cytotoxic T cells against a single epitope of a tumor antigen.
    Rice J; Buchan S; Stevenson FK
    J Immunol; 2002 Oct; 169(7):3908-13. PubMed ID: 12244189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV T cell vaccines, the importance of clades.
    McMichael A; Mwau M; Hanke T
    Vaccine; 2002 May; 20(15):1918-21. PubMed ID: 11983245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design of a polyepitope construct for the induction of HLA-A0201-restricted HIV 1-specific CTL responses using HLA-A*0201 transgenic, H-2 class I KO mice.
    Firat H; Tourdot S; Ureta-Vidal A; Scardino A; Suhrbier A; Buseyne F; Rivìere Y; Danos O; Michel ML; Kosmatopoulos K; Lemonnier FA
    Eur J Immunol; 2001 Oct; 31(10):3064-74. PubMed ID: 11592083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effective induction of type 1 cytotoxic T cell responses in mice with DNA vaccine encoding two hepatitis C virus cytotoxic T lymphocyte epitopes.
    Shi L; Liu S; Fan GX; Sheng L; Ren HX; Yuan YK
    Viral Immunol; 2006; 19(4):702-11. PubMed ID: 17201665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Mycobacterium tuberculosis CTL epitopes restricted by HLA-A*0201 in HHD mice.
    Rafiei A; Kiutade Y
    Iran Biomed J; 2007 Jan; 11(1):23-31. PubMed ID: 18051701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural mutants of HIV CTL epitopes with enhanced immunogenicity as potential vaccine candidates.
    Blondelle SE; Moya R; Schroder K; Osawa K; Wilson DB
    Adv Exp Med Biol; 2009; 611():379-82. PubMed ID: 19400233
    [No Abstract]   [Full Text] [Related]  

  • 31. Effective induction of HIV-specific CTL by multi-epitope using gene gun in a combined vaccination regime.
    Hanke T; Neumann VC; Blanchard TJ; Sweeney P; Hill AV; Smith GL; McMichael A
    Vaccine; 1999 Feb; 17(6):589-96. PubMed ID: 10075166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of multiple cytotoxic T lymphocyte responses in mice by a multiepitope DNA vaccine against dengue virus serotype 1.
    Chen XY; Li Z; Zhong XZ; Chen B; Duan ZL; Wen JS
    Microbiol Immunol; 2016 Dec; 60(12):835-845. PubMed ID: 27981613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from a long-term nonprogressing HIV-1-infected individual.
    Harrer T; Harrer E; Barbosa P; Kaufmann F; Wagner R; Brüggemann S; Kalden JR; Feinberg M; Johnson RP; Buchbinder S; Walker BD
    J Immunol; 1998 Nov; 161(9):4875-81. PubMed ID: 9794421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple Approaches for Increasing the Immunogenicity of an Epitope-Based Anti-HIV Vaccine.
    Rosa DS; Ribeiro SP; Fonseca SG; Almeida RR; Santana VC; Apostólico Jde S; Kalil J; Cunha-Neto E
    AIDS Res Hum Retroviruses; 2015 Nov; 31(11):1077-88. PubMed ID: 26149745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A CD8+ T cell heptaepitope minigene vaccine induces protective immunity against Chlamydia pneumoniae.
    Pinchuk I; Starcher BC; Livingston B; Tvninnereim A; Wu S; Appella E; Sidney J; Sette A; Wizel B
    J Immunol; 2005 May; 174(9):5729-39. PubMed ID: 15843575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different hepatitis C virus nonstructural protein 3 (Ns3)-DNA-expressing vaccines induce in HLA-A2.1 transgenic mice stable cytotoxic T lymphocytes that target one major epitope.
    Brinster C; Muguet S; Lone YC; Boucreux D; Renard N; Fournillier A; Lemonnier F; Inchauspé G
    Hepatology; 2001 Dec; 34(6):1206-17. PubMed ID: 11732011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracellular delivery of a novel multiepitope peptide vaccine by an amphipathic peptide carrier enhances cytotoxic T-cell responses in HLA-A*201 mice.
    Dakappagari NK; Sundaram R; Rawale S; Liner A; Galloway DR; Kaumaya PT
    J Pept Res; 2005 Feb; 65(2):189-99. PubMed ID: 15705163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenicity testing of a novel engineered HIV-1 envelope gp140 DNA vaccine construct.
    Kumar S; Yan J; Muthumani K; Ramanathan MP; Yoon H; Pavlakis GN; Felber BK; Sidhu M; Boyer JD; Weiner DB
    DNA Cell Biol; 2006 Jul; 25(7):383-92. PubMed ID: 16848679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA fusion gene vaccines induce cytotoxic T-cell attack on naturally processed peptides of human prostate-specific membrane antigen.
    Vittes GE; Harden EL; Ottensmeier CH; Rice J; Stevenson FK
    Eur J Immunol; 2011 Aug; 41(8):2447-56. PubMed ID: 21604260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repertoire and immunofocusing of CD8 T cell responses generated by HIV-1 gag-pol and expression library immunization vaccines.
    Singh RA; Barry MA
    J Immunol; 2004 Oct; 173(7):4387-93. PubMed ID: 15383568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.